Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?

Thomas Walter; Jean Yves Scoazec; Christophe Couderc; Julien Forestier; Colette Roche; Jean Alain Chayvialle; Catherine Lombard-Bohas

doi:10.3109/0284186X.2011.562919

Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?

Thomas Walter, Jean Yves Scoazec, Christophe Couderc, Julien Forestier, Colette Roche, Jean Alain Chayvialle, Catherine Lombard-Bohas

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	731-732
Nombre de pages	2
journal	Acta Oncologica
Volume	50
Numéro de publication	5
Les DOIs	https://doi.org/10.3109/0284186X.2011.562919
état	Publié - 1 janv. 2011

Accès au document

10.3109/0284186X.2011.562919

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{669d6826943249dcad03eb32da3d5fb6,

title = "Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?",

author = "Thomas Walter and Scoazec, {Jean Yves} and Christophe Couderc and Julien Forestier and Colette Roche and Chayvialle, {Jean Alain} and Catherine Lombard-Bohas",

year = "2011",

month = jan,

day = "1",

doi = "10.3109/0284186X.2011.562919",

language = "English",

volume = "50",

pages = "731--732",

journal = "Acta Oncologica",

issn = "0284-186X",

number = "5",

}

TY - JOUR

T1 - Well-differentiated pancreatic islet cell carcinoma

T2 - Is there reversibility in mTOR inhibitor resistance?

AU - Walter, Thomas

AU - Scoazec, Jean Yves

AU - Couderc, Christophe

AU - Forestier, Julien

AU - Roche, Colette

AU - Chayvialle, Jean Alain

AU - Lombard-Bohas, Catherine

PY - 2011/1/1

Y1 - 2011/1/1

UR - http://www.scopus.com/inward/record.url?scp=79956097509&partnerID=8YFLogxK

U2 - 10.3109/0284186X.2011.562919

DO - 10.3109/0284186X.2011.562919

M3 - Letter

AN - SCOPUS:79956097509

SN - 0284-186X

VL - 50

SP - 731

EP - 732

JO - Acta Oncologica

JF - Acta Oncologica

IS - 5

ER -